↓ Skip to main content

Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care

Overview of attention for article published in PharmacoEconomics, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
108 Mendeley
Title
Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care
Published in
PharmacoEconomics, September 2012
DOI 10.2165/00019053-200220080-00004
Pubmed ID
Authors

Craig Anderson, Cliona Ni Mhurchu, Paul M. Brown, Kristie Carter

Abstract

Limited information exists on the best way to organise stroke rehabilitation after hospital discharge and the relative costs of such services. To review the evidence of the cost effectiveness of services that accelerate hospital discharge and provide home-based rehabilitation for patients with acute stroke. A systematic review with economic analysis of published randomised clinical trials (available to March 2001) comparing early hospital discharge and domiciliary rehabilitation with usual care in patients with stroke was conducted. From included studies, data were extracted on study quality; major clinical outcomes including hospital stay, death, institutionalisation, disability, and readmission rates; and resource use associated with hospital stay, rehabilitation, and community services. The resources were priced using Australian dollars ($A) healthcare costs. The outcomes and costs of the new intervention were compared with standard care. Seven published trials involving 1277 patients (54% men; mean age 73 years) were identified. The pooled data showed that overall, a policy of early hospital discharge and domiciliary rehabilitation reduced total length of stay by 13 days [95% confidence interval (CI): -19 to -7 days]. There was no significant effect on mortality (odds ratio = 0.95; 95% CI: 0.65 to 1.38) or other clinical outcomes making a cost minimisation analysis for the economic analysis appropriate. The overall mean costs were approximately 15% lower for the early discharge intervention [$A16 016 ($US9941) versus $A18 350] ($US11 390)] compared with standard care. A policy of early hospital discharge and home-based rehabilitation for patients with stroke may reduce the use of hospital beds without compromising clinical outcomes. Our analysis shows this service to be a cost saving alternative to conventional in-hospital stroke rehabilitation for an important subgroup of patients with stroke-related disability.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Malaysia 1 <1%
United States 1 <1%
Unknown 104 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 18%
Student > Master 16 15%
Student > Ph. D. Student 11 10%
Student > Bachelor 9 8%
Other 5 5%
Other 18 17%
Unknown 30 28%
Readers by discipline Count As %
Medicine and Dentistry 32 30%
Nursing and Health Professions 9 8%
Engineering 7 6%
Neuroscience 6 6%
Social Sciences 5 5%
Other 14 13%
Unknown 35 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#5,446,994
of 25,374,917 outputs
Outputs from PharmacoEconomics
#570
of 1,992 outputs
Outputs of similar age
#39,165
of 189,602 outputs
Outputs of similar age from PharmacoEconomics
#106
of 549 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 549 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.